EcoDrugPlus

Histone Deacetylase 10

Ensembl ID : ENSLOCG00000015364
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSLOCG00000014033
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSLOCG00000016977
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSLOCG00000012055
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSLOCG00000009104
Gene Symbol: HDAC4
1 Cross references
262 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSLOCG00000005209
Gene Symbol: HDAC7
1 Cross references
260 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSLOCG00000011383
Gene Symbol: HDAC9
2 Cross references
234 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSLOCG00000018153
Gene Symbol: HCAR1
4 Cross references
240 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSLOCG00000014551
Gene Symbol: HCN4
3 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSLOCG00000001293
Gene Symbol: HCRTR1
4 Cross references
96 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSLOCG00000016905
Gene Symbol: HCRTR2
3 Cross references
199 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSLOCG00000007846
Gene Symbol: LOC102685895
3 Cross references
240 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).